>
Repro Med Systems Inc logo

KRMD - Repro Med Systems Inc Share Price

$2.77 -0.3  -9.0%

Last Trade - 6:45pm

Sector
Healthcare
Size
Small Cap
Market Cap £97.8m
Enterprise Value £78.0m
Revenue £17.5m
Position in Universe 4887th / 6850
Bullish
Bearish
Unlock KRMD Revenue
Momentum
Relative Strength (%)
1m -27.0%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -76.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
348.4
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
12.2 12.3 13.3 17.4 23.2 24.2 22.7 26.9 +14.6%
+3.0 +0.5 +261.9 -89.6
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020,Repro-Med Systems, Inc. revenues increased 4% to $24.2M.Net loss totaled $1.2M vs. income of $564K. Revenuesreflect an increase in demand for the Company's productsand services due to favorable market conditions. Net lossreflects Selling, general and administrative increase of23% to $12M (expense), Research and development increase of75% to $1.3M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

KRMD Revenue Unlock KRMD Revenue

Net Income

KRMD Net Income Unlock KRMD Revenue

Normalised EPS

KRMD Normalised EPS Unlock KRMD Revenue

PE Ratio Range

KRMD PE Ratio Range Unlock KRMD Revenue

Dividend Yield Range

KRMD Dividend Yield Range Unlock KRMD Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
KRMD EPS Forecasts Unlock KRMD Revenue
Profile Summary

REPRO MED SYSTEMS, INC. (RMS), is a developer and manufacturer of medical devices and supplies. The Company designs, manufactures and markets portable medical devices for the ambulatory infusion market and emergency medical applications. The Company's products include FREEDOM Infusion Systems, which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The devices are used for infusions administered in the home and alternate care settings. It focuses on home and specialty infusion solutions, emphasizing responsive problem-solving for customers.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated March 24, 1980
Public Since October 27, 1993
No. of Shareholders: 585
No. of Employees: 101
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 44,475,559
Free Float (0.0%)
Eligible for
ISAs
SIPPs
KRMD Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for KRMD
Upcoming Events for KRMD
Frequently Asked Questions for Repro Med Systems Inc
What is the Repro Med Systems Inc share price?

As of 6:45pm, shares in Repro Med Systems Inc are trading at $2.77, giving the company a market capitalisation of £97.8m. This share price information is delayed by 15 minutes.

How has the Repro Med Systems Inc share price performed this year?

Shares in Repro Med Systems Inc are currently trading at $2.77 and the price has moved by -69.75% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Repro Med Systems Inc price has moved by -79.15% over the past year.

What are the analyst and broker recommendations for Repro Med Systems Inc?

Of the analysts with advisory recommendations for Repro Med Systems Inc, there are there are currently 0 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Repro Med Systems Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Repro Med Systems Inc next release its financial results?

Repro Med Systems Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Repro Med Systems Inc dividend yield?

Repro Med Systems Inc does not currently pay a dividend.

Does Repro Med Systems Inc pay a dividend?

Repro Med Systems Inc does not currently pay a dividend.

When does Repro Med Systems Inc next pay dividends?

Repro Med Systems Inc does not currently pay a dividend.

How do I buy Repro Med Systems Inc shares?

To buy shares in Repro Med Systems Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Repro Med Systems Inc?

Shares in Repro Med Systems Inc are currently trading at $2.77, giving the company a market capitalisation of £97.8m.

Where are Repro Med Systems Inc shares listed? Where are Repro Med Systems Inc shares listed?

Here are the trading details for Repro Med Systems Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: KRMD
What kind of share is Repro Med Systems Inc?

Based on an overall assessment of its quality, value and momentum, Repro Med Systems Inc is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Repro Med Systems Inc share price forecast 2021?

Shares in Repro Med Systems Inc are currently priced at $2.77. At that level they are trading at 0.159% discount to the analyst consensus target price of 0.00.

Analysts covering Repro Med Systems Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.003 for the next financial year.

How can I tell whether the Repro Med Systems Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Repro Med Systems Inc. Over the past six months, the relative strength of its shares against the market has been -60.54%. At the current price of $2.77, shares in Repro Med Systems Inc are trading at -50.45% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Repro Med Systems Inc PE Ratio?

The Repro Med Systems Inc PE ratio based on its reported earnings over the past 12 months is 0.347k. The shares are currently trading at $2.77.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Repro Med Systems Inc?

Repro Med Systems Inc's management team is headed by:

Karen Fisher - CFO
David Anderson - IND
Joseph Manko - LED
Daniel Goldberger - DRC
Robert Allen - IND
James Beck - DRC
Manuel Marques - COO
R. John Fletcher - CHM
Linda Tharby - PRE
Who are the major shareholders of Repro Med Systems Inc?

Here are the top five shareholders of Repro Med Systems Inc based on the size of their shareholding:

Horton Capital Management LLC Hedge Fund
Percentage owned: 24.16% (10.7m shares)
First Light Asset Management, LLC Investment Advisor
Percentage owned: 13.2% (5.87m shares)
Frommer (Kathy S) Individual Investor
Percentage owned: 3.86% (1.72m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 3.68% (1.63m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 3.22% (1.43m shares)
Similar to KRMD
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.